Early and Late Results after Surgical Mitral Valve Repair: A High-Volume Center Experience
The Thoracic and Cardiovascular Surgeon · 01.12.2024 · 72 (08) · 624-630
DOI: 10.1055/a-2266-7677 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.12.2024. Verfasst von Julia Götte und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Cardio-Thoracic Surgery, Herz- und Diabeteszentrum Nordrhein-Westfalen, Bad Oeynhausen, Nordrhein-Westfalen, Germany. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Mitral Valve, Thoracotomy, Sternotomy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Surgical mitral valve repair is the gold standard treatment of severe primary mitral regurgitation (MR). In the light of rapidly evolving percutaneous technologies, current surgical outcome data are essential to support heart-team-based decision-making.
Methods
This retrospective, high-volume, single-center study analyzed in 1779 patients with primary MR early morbidity and mortality, postoperative valve function, and long-term survival after mitral valve (MV) repair. Surgeries were performed between 2009 and 2022. Surgical approaches included full sternotomy (FS) and right-sided minithoracotomy (minimally invasive cardiac [MIC] surgery).
Results
Of the surgeries (mean age: 59.9 [standard deviation:11.4] years; 71.5% males), 85.6% (n = 1,527) were minithoracotomies. Concomitant procedures were performed in 849 patients (47.7%), including tricuspid valve and/or atrial septal defect repair, cryoablation, and atrial appendage closure. The majority of patients did not need erythrocyte concentrates. Mediastinitis and rethoracotomy for bleeding rates were 0.1 and 4.3%, respectively. Reoperation before discharge for failed repair was necessary in 12 patients (0.7%). Freedom from more than moderate MR was > 99%. Thirty-day mortality was 0.2% and did not differ significantly between groups (p = 0.37). Median follow-up was 48.2 months with a completeness of 95.9%. Long-term survival was similar between groups (p = 0.21). In the FS and MIC groups, 1-, 5-, and 10-year survival rates were 98.8 and 98.8%, 92.9 and 94.4%, and 87.4 and 83.1%, respectively.
Conclusion
MV surgery, both minimally invasive and via sternotomy, is associated with high repair rates, excellent perioperative outcomes, and long-term survival. Data underscore the effectiveness of surgical repair in managing MR, even in the era of advancing interventional techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Clinic for Cardio-Thoracic Surgery, Herz- und Diabeteszentrum Nordrhein-Westfalen, Bad Oeynhausen, Nordrhein-Westfalen, Germany.
ORCID-Profile: Armin Zittermann
Zitieren
APA
Götte, J., Zittermann, A., Deutsch, M. A., Schramm, R., Bleiziffer, S., Renner, A., & Gummert, J. F. (2024). Early and Late Results after Surgical Mitral Valve Repair: A High-Volume Center Experience. The Thoracic and Cardiovascular Surgeon, 72(08), 624-630. https://doi.org/10.1055/a-2266-7677
Vancouver
Götte J, Zittermann A, Deutsch MA, Schramm R, Bleiziffer S, Renner A, et al. Early and Late Results after Surgical Mitral Valve Repair: A High-Volume Center Experience. The Thoracic and Cardiovascular Surgeon. 2024;72(08):624-630. doi:10.1055/a-2266-7677
BibTeX
@article{Gtte2024,
author = {Götte, Julia and Zittermann, Armin and Deutsch, Marcus-Andre and Schramm, Rene and Bleiziffer, Sabine and Renner, Andre and Gummert, Jan F},
title = {Early and Late Results after Surgical Mitral Valve Repair: A High-Volume Center Experience},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2024},
volume = {72},
number = {08},
pages = {624--630},
doi = {10.1055/a-2266-7677}
}
EUVIMED